| NAME |
LACOSAMIDE 10MG/ML SOLN,ORAL |
| VA GENERIC NAME |
LACOSAMIDE |
| DOSAGE FORM |
SOLN,ORAL |
| FDA MED GUIDE |
Lacosamide_Soln_(Generic)_(2022).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Schedule V |
| STRENGTH |
10 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
LACOSAMIDE SOLN,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
- COPAY END DATE: 2022-06-01 00:00:00
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2022-06-02 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
LACOSAMIDE 10MG/ML ORAL SOLN |
| VA PRODUCT IDENTIFIER |
L0511 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4030029 |
| EFFECTIVE DATE/TIME |
-
- 2010-08-13 00:00:00
- STATUS: ACTIVE
|
